Share Name Share Symbol Market Type Share ISIN Share Description
Microgen Plc LSE:MCGN London Ordinary Share GB00BVVHWX30 ORD 6 3/7P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.00p -0.31% 319.50p 319.00p 320.00p 319.75p 319.50p 319.75p 11,394 10:22:29
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Software & Computer Services 43.0 7.9 10.6 30.1 194.26

Microgen (MCGN) Latest News

More Microgen News
Microgen Takeover Rumours

Microgen (MCGN) Share Charts

1 Year Microgen Chart

1 Year Microgen Chart

1 Month Microgen Chart

1 Month Microgen Chart

Intraday Microgen Chart

Intraday Microgen Chart

Microgen (MCGN) Discussions and Chat

Microgen Forums and Chat

Date Time Title Posts
10/11/200517:32MICROGEN - a MICRO-GEM?207.00
08/7/200319:10Microgen - its electriccccccccccccccc30.00
18/12/200215:06Oversold>>>>> ahead of interims24.00
27/6/200217:22Any Views on Microgen ?11.00

Add a New Thread

Microgen (MCGN) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Microgen trades in real-time

Microgen (MCGN) Top Chat Posts

Microgen Daily Update: Microgen Plc is listed in the Software & Computer Services sector of the London Stock Exchange with ticker MCGN. The last closing price for Microgen was 320.50p.
Microgen Plc has a 4 week average price of 265p and a 12 week average price of 205p.
The 1 year high share price is 325p while the 1 year low share price is currently 133p.
There are currently 60,802,688 shares in issue and the average daily traded volume is 194,956 shares. The market capitalisation of Microgen Plc is £194,264,588.16.
firtashia: Abnormally high volume traded today; whilst its a perfectly good update I didnt think it would drive such a positive response in the share price. Not complaining though.
shauney2: From citywire Old Mutual manager Nick Williamson has upped his stake in wealth management and accounting software specialist Microgen (MCGN) as its share have spiked to a post tech-bubble high. Williamson increased his investment from below a disclosable level to 5.5% of the business worth just under £9 million at a share price of 268p, the highest since April 2001. The shares are held in the £173 million Old Mutual UK Smaller Companies Focus fund. Microgen has shot up 16% this month alone, capping an 82% climb over the last 12 months. The latest leg up followed 2016 results showing revenue 35% higher at £43 million and profit 26% higher at £9.5 million. The company upped its full-year dividend 19% to 5p per share. The rally has taken it to within a sliver of Investec’s recently-confirmed 270p target price however, on a price multiple of 27 times last year’s earnings.
nspal: Does anyone have confirmed data on the price levels for performance related stock option awards to MCGN senior management? I recently read that the previous chairman's potential awards were tied into share price rises to 200p, 250p and 300p before November 2018.
simon gordon: Tech Market View - 22/10/15: Microgen finds new Chairman After reporting on a more positive half year in July, see here, Microgen, the Big Data and Financial Services software company, has issued a very brief trading update as it announces some Board changes. The company’s two major businesses are continuing to “perform in line with the Board’s expectations”, with 95% of the total expected revenue for the current year now contracted. More interestingly, the company has announced that they have found a replacement for the outgoing Chairman Martyn Ratcliffe. Ivan Martin (ex-Misys and currently Non-Exec Chairman at FDM Group and RED) will take the reins as Non-Executive Chairman after the 2015 results are announced. By that time the two MDs of the operating businesses will have formally joined the Board. The new management structure will hopefully lead to a faster pace of change across the business. The past four years have seen declining revenues and pre-tax profits and a falling share price, relieved only by the management returning large amounts of cash to shareholders. A major “strategic review” generated only a handful of small acquisitions and no visible change (see here and work back). The markets where Microgen is active are interesting, even exciting. Let’s hope that Microgen itself can generate a bit more interest in the coming years.
speedsgh: 2bluelynn - Think you may have misunderstood the situ here. Part of the company is being returned to shareholders in the form of cash. There is no option for receiving more ordinary shares instead of cash. The return of cash is being effected thro the issue of B and C shares. The only decision you have to make is whether you wish to receive the cash return via B shares (cash return will be treated as a capital gain for tax purposes) or via C shares (cash return will be treated as income for tax purposes). If you don't make an election, you will automatically be allocated C shares + the cash return will be paid out as dividend income. After the return of cash, you will hold the same number of shares in a smaller company. However, in order to maintain the share price at roughly the same level as prior to the return of cash, the company is also proposing a 7-for-9 consolidation of the ordinary shares. So, if one was to own 900 shares prior to the consolidation, post consolidation the share price would remain the same but you would own 700 shares (the difference in value between your shreholding pre/post the share consolidation is being returned to you via the Return of Cash). Hope this helps. Not sure I can explain it more simply.
2bluelynn: So is it best to take the dividend as cash ?or take the 7 for 9 shares im puzzled ? Any views out there from you clever people ... I have 7500 of these so want to make the right choice I take it once the shares are issued the share price will drop by approx 22% due to the consolidation so to a £1 ish area Any advice out there ,maybe NTrader has a view ,I seem to think he has a load of these tucked away . Many thanks in advance
speedsgh: EI - Will the return of capital not be broadly neutral seeing as there will also be a share consolidation will occur alongside the return? I note that the final dividend has been maintained at the same level as last year. Struggling to get my head around whether MCGN is a decent investment or not. Share price performance in recent yrs has been disappointing. "the Board is proposing to return to shareholders approximately £20 million in cash, equivalent to 27 pence per share, ("Return of Value") by way of a B and C share scheme ("Scheme"). The Scheme provides shareholders (other than certain overseas shareholders) with a choice of receiving the cash in the form of income or capital provided that the Return of Value is completed prior to 6 April 2015. The Return of Value will be accompanied by a proportional share consolidation to maintain broad comparability of the share price and return per share of the ordinary shares before and after the creation of the B and C shares."
varies: The strategic review tells us that Mr Martyn Radcliffe,who owns about 6% of the capital, will not be tendering any of his shares and that his Incentive Awards only come into play when the share price exceeds 200p. Given his past successes, I am inclined to hold fast and, indeed, increase my holding.
checkers2: Yes agree country boy, in play now. The directors here are quite "old school", they play with a straight bat - and I don't think they would have announced this today if there had been no interest from buyers for the divisions. Key point in todays announcement: Microgen is constrained as a result of being a small, independent public company. As a provider of enterprise solutions in a risk-averse market environment, the size of the group can be an inhibitor given the very large enterprise software companies with which MASD typically competes. As a result, the Board has determined this to be an appropriate time to evaluate the Group's future strategy to maximise the potential of Microgen's market-leading technology and applications and has therefore decided to undertake a strategic review of the Group. Current market cap doesn't make the company cheap(EV/EBITDA of 7.5 at share price of 1.30) But it could well be worth well more than the current share price in the right hands. North of 1.80 would be very good work from the directors.
gleach23: yes i hope so janeann...i added today on the back of the buying and subsequent tick up as these can put on a sprint from time to time it's funny that the large transactions that nobody can make head nor tail of while the share price pauses are followed by more modest transactions that do get the share price moving and which are obviously buys
Microgen share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20170426 10:06:12